C. Tindell

发表

Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure.

P. Giresi, J. Settleman, Kuan-Bei Chen, 2017, Cancer cell.

An Alternative Approach to ChIP-Seq Normalization Enables Detection of Genome-Wide Changes in Histone H3 Lysine 27 Trimethylation upon EZH2 Inhibition

Feng Zhao, Suchit Jhunjhunwala, Charles Hatton, 2016, PloS one.

Response differences between human CD4(+) and CD8(+) T-cells during CD28 costimulation: implications for immune cell-based therapies and studies related to the expansion of double-positive T-cells during aging.

A. Nel, R. Effros, C. June, 2000, Clinical Immunology.

Proteomic analyses identify a novel role for EZH2 in the initiation of cancer cell drug tolerance.

A. Masselot, D. Arnott, R. Pitti, 2020, Journal of proteome research.

The Physical Association of Protein Kinase Cθ with a Lipid Raft-Associated Inhibitor of κB Factor Kinase (IKK) Complex Plays a Role in the Activation of the NF-κB Cascade by TCR and CD281

A. Nel, C. Tindell, A. Khoshnan, 2000, The Journal of Immunology.

TCR and CD 28 B Cascade by κ in the Activation of the NFB Factor Kinase ( IKK ) Complex Plays a Role κ with a Lipid Raft-Associated Inhibitor of θ The Physical Association of Protein Kinase C

A. Nel, C. Tindell, A. Khoshnan, 2000 .

The NF-κB Cascade Is Important in Bcl-xL Expression and for the Anti-Apoptotic Effects of the CD28 Receptor in Primary Human CD4+ Lymphocytes1

A. Nel, B. Bennett, C. Tindell, 2000, The Journal of Immunology.

The NF-kB Cascade Is Important in Bcl-xL Expression and for the Anti-Apoptotic Effects of the CD28 Receptor in Primary Human CD4 Lymphocytes

B. Bennett, A. Nel, C. Tindell, 2000 .

Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth.

Brian Higgins, H. Scher, M. Sliwkowski, 2002, Cancer cell.

An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells.

P. Trojer, E. Jackson, D. Arnott, 2016, Nature chemical biology.

Epithelial membrane protein-1 is a biomarker of gefitinib resistance.

S. Shak, D. Agus, Anjali Jain, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer.

M. Gross, D. Agus, J. Katz, 2007, Clinical cancer research : an official journal of the American Association for Cancer Research.

β-2-Microglobulin Is an Androgen-Regulated Secreted Protein Elevated in Serum of Patients with Advanced Prostate Cancer

M. Gross, D. Agus, J. Katz, 2007, Clinical Cancer Research.

HER kinase axis receptor dimer partner switching occurs in response to EGFR tyrosine kinase inhibition despite failure to block cellular proliferation.

D. Agus, Anjali Jain, C. Tindell, 2010, Cancer research.

Mass Spectrometric Quantification of Histone Post-translational Modifications by a Hybrid Chemical Labeling Method

Jun Liang, A. Masselot, P. Trojer, 2015, Molecular & Cellular Proteomics.